三星醫療(601567.SH)對子公司寧波明州醫院增資5億元
格隆匯12月25日丨三星醫療(601567.SH)公佈,公司於2019年12月25日召開第四屆董事會第二十四次會議,審議並通過了《關於對下屬子公司寧波明州醫院有限公司增資的議案》,同意公司全資子公司寧波三星智能電氣有限公司以自有資金對公司下屬子公司寧波明州醫院有限公司投資5億元,其中2.5億元計入註冊資本,其餘部分計入資本公積。
寧波明州醫院有限公司註冊資本6.5億人民幣,經營範圍為根據2018年9月21日寧波市鄞州區衞生和計劃生育局核發的登記號為PDY60197433021216A1001的診療科目經營;會議服務;停車場服務;美容服務;驗光配鏡服務;健康管理諮詢;食品經營;母嬰護理(不含醫療診治服務);嬰幼兒洗浴服務;日用百貨、母嬰用品的銷售。
公司稱,本次增資完成後,明州醫院註冊資本為9億元,將進一步促進公司醫療產業的發展,推動公司戰略的有效實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.